Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketwatch.com - Kringle Pharma FY Parent Loss Y813.00M Vs Loss Y916.00M
Kringle Pharma FY Parent Loss Y813.00M Vs Loss Y916.00M
MarketWatch –

Kringle Pharma Inc. (4884.TO) Japan Year Ended September 30 PARENT 2026 2025 Revenue Y442.00 mln Y72.00 mln Operating Profit (Y813.00 mln) (Y909.00 mln) Pretax Profit (Y810.00 mln) (Y914.00 mln) Net Profit (Y813.00 mln) (Y916.00 mln) Per share…

wsj.com - Nikkei Flat, Supported by Bank, Pharma Stocks
Nikkei Flat, Supported by Bank, Pharma Stocks
Wall Street Journal –

0023 GMT — Japan 's Nikkei Stock Average is flat at 60451.02 as gains in bank and pharmaceutical shares offset losses in technology and machinery stocks. Mitsubishi UFJ Financial Group rises 1.9% and Takeda Pharmaceutical is 2.0% higher…

marketwatch.com - Fuji Pharma FY Net Y2.83B Vs Net Y3.00B
Fuji Pharma FY Net Y2.83B Vs Net Y3.00B
MarketWatch –

Fuji Pharma Co. Ltd. (4554.TO) Japan Year Ended September 30 GROUP 2026 2025 Revenue Y62.39 bln Y51.68 bln Operating Profit Y6.36 bln Y4.99 bln Pretax Profit Y6.18 bln Y4.46 bln Net Profit Y2.83 bln Y3.00 bln Per share Earnings Y111.18 Y122.94…

theguardian.com - Julia Kollewe - Pharma firms' focus on weight-loss drugs could put insulin supply at risk, experts warn
Pharma firms' focus on weight-loss drugs could put insulin supply at risk, experts warn
The Guardian –

The gold rush into GLP-1 weight-loss drugs risks diverting pharmaceutical firms' attention away from diabetes treatments such as insulin, the head of the Access to Medicine Foundation has warned. GLP-1 blockbuster medications such as Novo Nordisk's…

broadcastnow.co.uk - Ellie Kahn - Mums vs Big Pharma draws 500K
Mums vs Big Pharma draws 500K
Broadcast –

MONDAY: BBC2 drugs scandal doc short of average as 5's Police: Suspect No 1 wins 9pm Up to the minute industry news Agenda-setting interviews with key industry figures Insight into the latest programme performances Ratings data with viewing trends…

adweek.com - Katie Duffy - Omnicom Makes Tom Schwenger CEO of Omnicom Health Marketing
Omnicom Makes Tom Schwenger CEO of Omnicom Health Marketing
ADWEEK –

Omnicom appointed Tom Schwenger as chief executive officer of Omnicom Health's marketing branch, the company announced last week. Schwenger will manage Omnicom Health's global marketing agencies. This role will entail developing and implementing…

thehindubusinessline.com - Akhil Nallamuthu - Nifty Prediction Today - November 11, 2026: Nifty futures: Intraday outlook is positive
Nifty Prediction Today - November 11, 2026: Nifty futures: Intraday outlook is positive
The HinduBusinessLine –

Among the sectors, the few indices related to pharma and healthcare are in the red. Nifty Pharma has lost the most by declining 0.5 per cent. While most of the sectoral indices have advanced over 1 per cent, showing a strong broad-based buying…

techcrunch.com - Marina Temkin - Proximal Ventures raises debut fund to back startups bringing AI to drug development
Proximal Ventures raises debut fund to back startups bringing AI to drug development
TechCrunch –

While established venture firms continue to attract capital, first-time fund managers are facing one of the toughest fundraising environments in years. But that didn't stop Sahir Raoof, a former SignalFire investor and executive at two healthcare…

hotair.com - Ed Morrissey - WSJ: EU Learns Hard Old Lesson on Price Controls
WSJ: EU Learns Hard Old Lesson on Price Controls
HotAir –

What happens when governments employ price controls as part of a 'central planning' economy pushed by socialists? In every place it has been tried, the results are consistent. Little gets produced except shortages and excuses. For decades, the…

thehindu.com -  Ramya Kannan - Health Matters newsletter: A country bogged down by smog
Health Matters newsletter: A country bogged down by smog
The Hindu –

(In the weekly Health Matters newsletter, Ramya Kannan writes about getting to good health, and staying there. You can subscribe here to get the newsletter in your inbox.) Deepavali, once the festival of lights, is now, in India, completely…

seekingalpha.com - Rob Williams - Capricor Therapeutics shares rise as FDA decision nears (CAPR:NASDAQ)
Capricor Therapeutics shares rise as FDA decision nears (CAPR:NASDAQ)
Seeking Alpha –

Capricor Therapeutics (CAPR) shares rose 4.4% in extended trading Tuesday after the biotechnology company reported a wider third-quarter loss and missed Wall Street estimates for revenue and earnings. The San Diego-based company reported no revenue…

seekingalpha.com - Albert Anthony - Bank of Nova Scotia Stock Expands And Keeps Buy Rating Ahead Of Q4 Results (NYSE:BNS)
Bank of Nova Scotia Stock Expands And Keeps Buy Rating Ahead Of Q4 Results (NYSE:BNS)
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and a contributing analyst to investing platforms like Seeking Alpha since 2023, where he has over + 2,000 followers and has covered hundreds of stocks in multiple sectors including…

bluewin.ch - 1,000 liters of hydrochloric acid spilled - toxic cloud of vapor over Liestal
1,000 liters of hydrochloric acid spilled - toxic cloud of vapor over Liestal
bluewin.ch –

In the Oristal industrial park in Liestal, Canton Basel-Landschaft, approximately 1,000 liters of hydrochloric acid leaked at the Dragon Pharma facility. According to Alertswiss, a cloud of vapor has formed. Authorities are warning of the possible…

econotimes.com - Celia Rowan - Venkatraman Sets Conditional Nov. 11 Levels for Three Indian Stocks
Venkatraman Sets Conditional Nov. 11 Levels for Three Indian Stocks
EconoTimes –

A Mint column by NeoTrader co-founder Raja Venkatraman set conditional Nov. 11 trading levels for three Indian stocks, with stop-losses and two-month targets following a one-day exchange holiday. National Stock Exchange of India (NSE) price…

fastcompany.com - Greg Satell - Before you trust consultants' 'research,' look for these red flags
Before you trust consultants' 'research,' look for these red flags
Fast Company –

When Enron, which Fortune named “America's Most Innovative Company” for six consecutive years, collapsed in 2001, there was no shortage of blame to go around. Many blamed corruption and greed, others hubris, and still others…

Receive a Daily briefing on Pharma Industry News

Get Started